全文获取类型
收费全文 | 17375篇 |
免费 | 1489篇 |
国内免费 | 284篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 374篇 |
妇产科学 | 17篇 |
基础医学 | 2519篇 |
口腔科学 | 217篇 |
临床医学 | 1651篇 |
内科学 | 5027篇 |
皮肤病学 | 312篇 |
神经病学 | 140篇 |
特种医学 | 386篇 |
外科学 | 1834篇 |
综合类 | 2243篇 |
现状与发展 | 3篇 |
预防医学 | 458篇 |
眼科学 | 104篇 |
药学 | 1892篇 |
7篇 | |
中国医学 | 1880篇 |
肿瘤学 | 65篇 |
出版年
2024年 | 16篇 |
2023年 | 421篇 |
2022年 | 493篇 |
2021年 | 686篇 |
2020年 | 750篇 |
2019年 | 754篇 |
2018年 | 714篇 |
2017年 | 764篇 |
2016年 | 684篇 |
2015年 | 555篇 |
2014年 | 1144篇 |
2013年 | 2108篇 |
2012年 | 864篇 |
2011年 | 948篇 |
2010年 | 691篇 |
2009年 | 799篇 |
2008年 | 745篇 |
2007年 | 809篇 |
2006年 | 668篇 |
2005年 | 549篇 |
2004年 | 483篇 |
2003年 | 332篇 |
2002年 | 350篇 |
2001年 | 275篇 |
2000年 | 243篇 |
1999年 | 235篇 |
1998年 | 224篇 |
1997年 | 178篇 |
1996年 | 173篇 |
1995年 | 167篇 |
1994年 | 160篇 |
1993年 | 148篇 |
1992年 | 132篇 |
1991年 | 93篇 |
1990年 | 99篇 |
1989年 | 79篇 |
1988年 | 75篇 |
1987年 | 78篇 |
1986年 | 73篇 |
1985年 | 71篇 |
1984年 | 78篇 |
1983年 | 35篇 |
1982年 | 65篇 |
1981年 | 42篇 |
1980年 | 23篇 |
1979年 | 16篇 |
1978年 | 16篇 |
1977年 | 12篇 |
1976年 | 11篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Tofacitinib is an immunosuppressive and disease-modifying therapy in rheumatoid arthritis. It may result in many infections flaring up. It is important to take precautions of all kinds (cardiovascular, malignancy, infections etc.) before starting tofacitinib. In this article, we have highlighted important steps where we need to take precautions before starting tofacitinib. 相似文献
2.
目的探讨白细胞介素37b重组蛋白(rmIL-37b)通过调节CD39/ATP轴抑制树突状细胞(DC)诱导类风湿性关节炎(RA)大鼠炎症反应的机制。方法将SD大鼠随机分为空白对照组(CTL)、CIA模型组、rmIL-37b 5μg/kg组、rmIL-37b 10μg/kg组,每组各10只。除了空白对照组外,其余大鼠采用含有卡介苗的完全弗氏佐剂和牛Ⅱ型胶原混合乳液免疫刺激,建立CIA模型。确定建模成功当天(D0),rmIL-37b组分别尾静脉注射5μg/kg、10μg/kg rmIL-37b;CTL组和CIA模型组注射相同体积的(1 ml/kg)生理盐水,连续给药15 d。免疫组化法检测滑膜组织Nod样受体蛋白3(NRPL3)炎症小体的表达,流式细胞术检测DC表型,另外试剂盒检测血清三磷酸腺苷(ATP)和免疫学指标。结果与CIA模型组相比,rmIL-37b 10μg/kg组大鼠足容积、AI值、NLRP3炎症小体表达量、血清ATP、IL-1β、IL-18、肿瘤坏死因子α(TNF-α)、抗Ⅱ型胶原抗体亚型(anti-ColⅡ-IgG、anti-ColⅡ-IgG2a)水平均降低,同时DC表面CD... 相似文献
3.
4.
5.
《The Egyptian Rheumatologist》2022,44(4):361-365
Juvenile Idiopathic Arthritis (JIA) is a multi-factorial disease influenced both by environmental and genetic factors. Progressive pseudorheumatoid dysplasia (PPD) is a rare autosomal recessive genetic disorder affecting multiple joints, mimicking JIA. Aim of the work: to reveal the frequency of HLA-DR types among the studied patients and to correlate the different allele variations clinically. Patients and methods: Thirty JIA patients, in addition to 15 molecularly diagnosed PPD patients were subjected to full history taking and clinical examination. HLA-DRB1 typing was performed to 24/30 JIA and 12/15 PPD cases and thirty healthy age and sex matched children who were included as a control group. Results: The JIA patients were 22 females and 8 males with mean age of 15.8 ± 1.96 years and disease duration 5.3 ± 4.4 years. PPD patients were 8 males and 7 females with mean age of 8.7 ± 3.06 years and disease duration 3.95 ± 2.68 years. A significant frequency of HLA-DRB 04 (p = 0.049) among JIA patients was present in comparison to the controls (OR = 2.81, CI:1.02–7.75), other risky alleles were HLA-DRB 10, 13 and 15. However, HLA-DRB 01, 03, 07, 11 and 14 were found to be protective. HLA-DRB 01, 04, 10 and 13 were found to be risky alleles in PPD. However, HLA 03, 07, 11 and 15 were found to be protective alleles among PPD patients. Conclusion: HLA-DRB 04 was found in a higher frequency in JIA patients with a significant difference in comparison to the controls, denoting that it may play a role in the genetic pathogenesis of JIA. 相似文献
6.
《The Egyptian Rheumatologist》2022,44(3):275-278
IntroductionRheumatoid arthritis (RA) is a multifactorial disease. Genetic predisposition and environmental triggers including infections are the major players of autoimmunity. We present a case of rheumatoid arthritis occurring after the coronavirus disease 2019(COVID-19) infection.Case presentationA 72-year-old woman with a medical history of hypertension and atrial fibrillation presented for a 2-month history of bilateral symmetric polyarthritis starting 2 weeks after asymptomatic COVID-19 infection. Physical examination showed swelling and tenderness of the metacarpophalangeal and proximal interphalangeal joints, wrists, and knees. She had increased inflammatory biomarkers (C-reactive protein:108 mg/L, erythrocyte sedimentation rate: 95 mm, alpha-2 and gamma-globulins, interleukin 6: 16.5 pg/mL). Immunological tests revealed positive rheumatoid factor (128 UI/mL), anti-cyclic citrullinated peptide antibodies (200UI/mL), anti-nuclear antibodies (1:320), and anti-SARS-CoV-2 IgG (12.24U/mL). She had the genotype: HLA-DRB1*04:11, HLA-DQB1*03:01, and HLA-DQB1* 03:02. Hands and feet radiographs did not show any erosion. Ultrasonography showed active synovitis and erosion of the 5th right metatarsal head. The diagnosis of RA was made. The patient received intravenous pulses of methylprednisolone (250 mg/day for 3 consecutive days) then oral corticosteroids (15 mg daily) and methotrexate (10 mg/week) were associated, leading to clinical and biological improvement.ConclusionDespite its rarity, physicians should be aware of the possibility of the occurrence of RA after COVID-19 infection. This finding highlights the autoimmune property of this emerging virus and raises further questions about the pathogenesis of immunological alterations. 相似文献
7.
8.
《Journal of infection and chemotherapy》2022,28(4):587-590
A 37-year-old man developed right ankle pain and swelling six days after being diagnosed with coronavirus disease (COVID-19). Despite conservative treatment, his ankle symptoms persisted. Magnetic resonance imaging and computed tomography showed synovial hypertrophy and bone erosion in the ankle. Following arthroscopic synovectomy, performed 69 days after the COVID-19 diagnosis, the pain improved significantly. The clinical course was consistent with that of reactive arthritis following severe acute respiratory syndrome coronavirus 2 infection. The pathological findings resembled rheumatoid nodules. The bone erosion may have originated from the inflammatory pathway, which resembles the mechanism of rheumatoid arthritis. 相似文献
9.
10.
目的 总结全身型幼年特发性关节炎(sJIA)合并巨噬细胞活化综合征(MAS)的早期临床特征、实验室及辅助检查特点,筛选对诊断MAS有预警作用的检测指标,并量化形成量表,以达到快速对疾病“早识别,早治疗,降低病死率”的目的。方法 回顾性分析2006年1月至2016年1月,北京儿童医院风湿免疫科收治sJIA合并MAS患儿的病例资料,在临床及辅助检查观测指标中筛选出对早期诊断MAS有评估意义的候选指标;通过ROC曲线的方法选择最佳的诊断界限值(Cut-off值);采用多因素Logistic回归分析MAS独立危险因素,效果以优势比(OR)表示,计算95%置信区间;经过同行评议对上述因素进行权重分值量化并最终形成积分表。结果 390例sJIA患儿,其中141例合并MAS。临床表现全部患儿均有高热、肝脾和(或)淋巴结进行性增大、血液系统受累,中枢神经系统受累患儿19例。单因素Logistic回归及ROC曲线分析结果显示,MAS组和重症sJIA组比较,10个变量存在显著差异(P<0.05)。Logistic回归分析结果显示,Fib ≤3.11g/L、WBC≤11.0×109/L、SF/ESR≥99.4及PLT≤260×109/L为MAS的独立危险因素。绘制模型ROC曲线,灵敏度和特异度分别为92.42%、81.20%。经过30位同行专家评议并投票,分别对上述患儿进行MAS诊断,并对各项临床表现及检验检查项目进行权重值评分,形成早期预警量表。结论 临床表现结合辅助检查结果,利用积分量表的形式,快速判断重症sJIA是否合并早期MAS,对诊断窗口提前,提高MAS诊断率,降低漏诊及前瞻性研究提供参考。 相似文献